These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The role of CXC chemokines and their receptors in cancer. Vandercappellen J; Van Damme J; Struyf S Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287 [TBL] [Abstract][Full Text] [Related]
26. Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site. Smith EW; Lewandowski EM; Moussouras NA; Kroeck KG; Volkman BF; Veldkamp CT; Chen Y Biochemistry; 2016 Oct; 55(40):5746-5753. PubMed ID: 27617343 [TBL] [Abstract][Full Text] [Related]
27. The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry. Farzan M; Babcock GJ; Vasilieva N; Wright PL; Kiprilov E; Mirzabekov T; Choe H J Biol Chem; 2002 Aug; 277(33):29484-9. PubMed ID: 12034737 [TBL] [Abstract][Full Text] [Related]
28. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha. Gozansky EK; Louis JM; Caffrey M; Clore GM J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815 [TBL] [Abstract][Full Text] [Related]
29. Unmasking ligand binding motifs: identification of a chemokine receptor motif by NMR studies of antagonist peptides. Booth V; Slupsky CM; Clark-Lewis I; Sykes BD J Mol Biol; 2003 Mar; 327(2):329-34. PubMed ID: 12628240 [TBL] [Abstract][Full Text] [Related]
30. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. Inngjerdingen M; Rolstad B; Ryan JC J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311 [TBL] [Abstract][Full Text] [Related]
31. Dual targeting of the chemokine receptors CXCR4 and ACKR3 with novel engineered chemokines. Hanes MS; Salanga CL; Chowdry AB; Comerford I; McColl SR; Kufareva I; Handel TM J Biol Chem; 2015 Sep; 290(37):22385-97. PubMed ID: 26216880 [TBL] [Abstract][Full Text] [Related]
33. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach. Costantini S; Raucci R; De Vero T; Castello G; Colonna G Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308 [TBL] [Abstract][Full Text] [Related]
34. Allosteric modulation of the chemokine receptor-chemokine CXCR4-CXCL12 complex by tyrosine sulfation. Sonawani A; Kharche S; Dasgupta D; Sengupta D Int J Biol Macromol; 2022 May; 206():812-822. PubMed ID: 35306016 [TBL] [Abstract][Full Text] [Related]
35. How do chemokines navigate neutrophils to the target site: Dissecting the structural mechanisms and signaling pathways. Rajarathnam K; Schnoor M; Richardson RM; Rajagopal S Cell Signal; 2019 Feb; 54():69-80. PubMed ID: 30465827 [TBL] [Abstract][Full Text] [Related]
36. A CXC chemokine SDF-1/PBSF: a ligand for a HIV coreceptor, CXCR4. Nagasawa T; Tachibana K; Kawabata K Adv Immunol; 1999; 71():211-28. PubMed ID: 9917914 [No Abstract] [Full Text] [Related]
37. Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor. Huang X; Shen J; Cui M; Shen L; Luo X; Ling K; Pei G; Jiang H; Chen K Biophys J; 2003 Jan; 84(1):171-84. PubMed ID: 12524273 [TBL] [Abstract][Full Text] [Related]
38. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer. Nazari A; Khorramdelazad H; Hassanshahi G Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185 [TBL] [Abstract][Full Text] [Related]
39. Characterization of a chimeric chemokine as a specific ligand for ACKR3. Ameti R; Melgrati S; Radice E; Cameroni E; Hub E; Thelen S; Rot A; Thelen M J Leukoc Biol; 2018 Aug; 104(2):391-400. PubMed ID: 29601107 [TBL] [Abstract][Full Text] [Related]
40. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies. Khare T; Bissonnette M; Khare S Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]